| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/10/2008 | US7384934 6-Fluoro-10-[3-(2-methoxy-ethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene; dopamine D2 and serotonin receptor anatagonist; neuroleptic agent, antidepressnt; psychological, bipolar disorders, psychosis, schizophrenia, acute mania |
| 06/10/2008 | US7384933 Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments |
| 06/10/2008 | US7384932 bradycardial agent, myocardial ischaemia, angina pectoris, myocardial infarct and associated rhythm disturbances, supraventricular rhythm disturbances, and heart failure; mixture of acetonitrile and water is preheated, ivabradine hydrochloride is added, cooled at room temperature |
| 06/10/2008 | US7384931 Constrained compounds as CGRP-receptor antagonists |
| 06/10/2008 | US7384930 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma |
| 06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
| 06/10/2008 | US7384928 7-side chain is substituted with aminothiazole and 3-position with a cyclic-type quarternary ammoniummethyl group; antibacterial activities against cephem-resistant Pseudomonas aeruginosa which produce beta -lactamase; antibiotic resistance; pharmacokinetics; high water solubility; injection |
| 06/10/2008 | US7384926 Administering estratriene-3-ol, 3,17 alpha -estradiol, estrone, or estriol |
| 06/10/2008 | US7384925 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
| 06/10/2008 | US7384924 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| 06/10/2008 | US7384923 Liposomes |
| 06/10/2008 | US7384922 Bicyclic 12 lactone ring macrolide, ketolide, and anhydrolide derivatives; antibacterial; cystic fibrosis |
| 06/10/2008 | US7384921 Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| 06/10/2008 | US7384920 Using a stilbene compound modified with hydroxy or alkoxy groups; antidiabetic agents; viricides |
| 06/10/2008 | US7384919 Nontoxic; spray drying or freeze drying |
| 06/10/2008 | US7384916 Methods and compositions for preventing and treating aging or photodamaged skin |
| 06/10/2008 | US7384909 Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents |
| 06/10/2008 | US7384907 Using tyrosine kinase (ABL) as tool to identify modulators which prevent bacterial and viral uptake into cells; treating parasitic infections; bactericides; viricides |
| 06/10/2008 | US7384764 Detecting cancerous and precancerous cells; obtain tissue sample, incubate wih tetrakis dyes, rince and remove unbound dye, detect fluorescence, fuorescence indicates cancerous or precancerous cells |
| 06/10/2008 | US7384656 Downregulating production of immunoglobulin E; prostaglandins; leukotrienes |
| 06/10/2008 | US7384654 Anti-Allergy composition and related method |
| 06/10/2008 | US7384653 Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 06/10/2008 | US7384652 Complexed-acidic-phospholipid-collagen composites for bone induction |
| 06/10/2008 | US7384651 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/10/2008 | US7384650 A skin permeation enhancer for enhancing absorption of a steroid hormone through the skin, containing an organic solvent, a fatty (C8-C20) alcohol ester of a hydroxy acid, a lower alkyl ester of hydroxy acid and a (C6-C18) fatty acid |
| 06/10/2008 | US7384648 coatings selected from retinol, retinal, retinoic acid or p-[(E)-2-(5, 6, 7, 8-tetrahydro-5, 5, 8, 8-tetramethyll-2-naphthyl)propenyl]-benzoic acid, used as grafts for eye tissues; biodegradable prosthetics |
| 06/10/2008 | US7384646 Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same |
| 06/10/2008 | US7384626 Quaternary ammonium functionalized dendritic polymers and N-Halamine functionalized dendritic polymers for capture and neutralization of biological and chemical warfare agents |
| 06/10/2008 | US7384625 Containing thiazolium compounds. |
| 06/10/2008 | US7384478 Apparatus and process for preparing crystalline particles |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/10/2008 | US7383970 Valve with a two-component seal |
| 06/10/2008 | CA2474280C Compositions containing alpha-2-adrenergic agonist components |
| 06/10/2008 | CA2431068C Crystalline forms of atorvastatin |
| 06/10/2008 | CA2429590C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/10/2008 | CA2427338C Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 06/10/2008 | CA2418614C Phosphonocephem compound |
| 06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | CA2376121C Stable xylometazoline and oxymetazoline solution |
| 06/10/2008 | CA2371827C Amide compounds for the potentiation of cholinergic activity |
| 06/10/2008 | CA2369070C 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/10/2008 | CA2367431C 6-o-substituted macrolides having antibacterial activity |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2345121C Pharmaceutical composition for the treatment of acute disorders |
| 06/10/2008 | CA2341814C Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 06/10/2008 | CA2329234C Controlled release peroral compositions of levosimendan |
| 06/10/2008 | CA2326517C New galenic preparations of meloxicam for oral administration |
| 06/10/2008 | CA2325933C Fatty acid derivatives of bile acids and bile acid derivatives |
| 06/10/2008 | CA2322790C Granulatimide derivatives for use in cancer treatment |
| 06/10/2008 | CA2319010C Pharmaceutical compositions |
| 06/10/2008 | CA2311530C Nasal solutions |
| 06/10/2008 | CA2310028C High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 06/10/2008 | CA2304331C Coated dosage units |
| 06/10/2008 | CA2302586C Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 06/10/2008 | CA2296665C Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents |
| 06/10/2008 | CA2288287C Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 06/10/2008 | CA2286719C Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s |
| 06/10/2008 | CA2259981C 6,7-oxygenated steroids and uses related thereto |
| 06/10/2008 | CA2252584C Treatment of carcinomas using squalamine in combination with other anti-cancer agents |
| 06/10/2008 | CA2250075C Methods for diagnosing and treating alzheimer's disease |
| 06/10/2008 | CA2250010C Denaturants for sympathomimetic amine salts |
| 06/10/2008 | CA2227607C Penicillaminamide derivatives |
| 06/10/2008 | CA2214100C Sustained release formulation containing three different types of polymers |
| 06/10/2008 | CA2210799C Valaciclovir hydrochloride in anhydrous crystalline form |
| 06/10/2008 | CA2191750C Virosome-mediated intracellular delivery of therapeutic agents |
| 06/10/2008 | CA2186915C Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/08/2008 | CA2572004A1 Tablets comprising entacapone and crospovidone |
| 06/06/2008 | CA2609837A1 Composition and method for supporting thermogenesis and lipid oxidation |
| 06/06/2008 | CA2609580A1 Composition for promoting cognitive attributes |
| 06/05/2008 | WO2008067566A1 Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators |
| 06/05/2008 | WO2008067549A2 Stabilized zolpidem pharmaceutical compositions |
| 06/05/2008 | WO2008067527A1 Inhibitors of protein tyrosine phosphatase for the treatment of muscle atrophy and related disorders |
| 06/05/2008 | WO2008067491A2 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity |
| 06/05/2008 | WO2008067481A1 Aza-indolyl compounds and methods of use |
| 06/05/2008 | WO2008067465A1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| 06/05/2008 | WO2008067451A1 Novel 3-benzylidine and 3-benzyl substituted chromanones |
| 06/05/2008 | WO2008067450A2 6-alkoxyalkyl estradiol derivatives and methods of use |
| 06/05/2008 | WO2008067436A2 Compounds and formulations suitable for radical scavenging |
| 06/05/2008 | WO2008067417A2 Nitroxides for use in treating or preventing hypercholesterolemia |
| 06/05/2008 | WO2008067390A2 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof |
| 06/05/2008 | WO2008067315A1 Therapeutic composition from goji (lycium barbarum l.), methods of making and using |
| 06/05/2008 | WO2008067288A2 Methods for inhibiting foreign body response to implanted materials |
| 06/05/2008 | WO2008067257A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 06/05/2008 | WO2008067222A1 Heterocyclic modulators of tgr5 |
| 06/05/2008 | WO2008067219A2 Quinazolinone modulators of tgr5 |
| 06/05/2008 | WO2008067177A2 Methods for the treatment of alcohol abuse, addiction and dependency |
| 06/05/2008 | WO2008067167A1 Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 06/05/2008 | WO2008067164A2 Solid pharmaceutical dosage formulations |
| 06/05/2008 | WO2008067121A2 Methods of treating cognitive impairment and dementia |
| 06/05/2008 | WO2008067120A2 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
| 06/05/2008 | WO2008067086A2 Compositions and methods for suppressing endometrial proliferation |
| 06/05/2008 | WO2008067060A2 Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue |
| 06/05/2008 | WO2008067039A2 Colchicine neoglycosides and methods for their synthesis and use |
| 06/05/2008 | WO2008067037A2 Novel formulations of proton pump inhibitors and methods of using these formulations |
| 06/05/2008 | WO2008067002A2 Azole nucleosides and use as inhibitors of rna and dna varial polymerases |
| 06/05/2008 | WO2008066916A1 Methods for the treatment of mood disorders |
| 06/05/2008 | WO2008066900A1 1,4 diamino bicyclic retigabine analogues as potassium channel modulators |